AVAXIA BIOLOGICS, Inc — Form D
AVAXIA BIOLOGICS, Inc of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-06. The offering totals $8.0M, of which $3.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2014-05-06
- Form: D
- Accession: 0001534899-14-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $3.1M
- Remaining: $4.9M
- Investors: 95
- Date of first sale: 2014-04-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-216859
Issuer
- Name: AVAXIA BIOLOGICS, Inc
- CIK: 0001534899
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 128 SPRING ST., STE 620, LEXINGTON, MA, 02421
- Phone: 781-861-0062
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| David S Donabedian | Director | Lexington, MA |
| Barbara S Fox | Director | Lexington, MA |
| Nada S Jain | Director | Lexington, MA |
| Henry S Kay | Director | Lexington, MA |
| Christopher S Kiritsy | Director | Lexington, MA |
| Robert S Manning | Director | Lexington, MA |
| David S Poorvin | Director | Lexington, MA |
| Barbara S Fox | Executive Officer | Lexington, MA |
| John S Edwards | Director | Lexington, MA |
| David S Poorvin | Executive Officer | Lexington, MA |
| David H Donabedian | Director | Lexington, MA |
| David C Dlesk | Executive Officer | Lexington, MA |
| Christopher F Kiritsy | Director | Lexington, MA |
| Eileen F Bostwick | Executive Officer | Lexington, MA |
| Jonathan S Fleming | Director | Lexington, MA |
Other filings by this issuer (6)
More